Among newly diagnosed IDH+ LrGG, the grade 2 gliomas demonstrated an elevated ratio of MI/tCho (p = 0.020) compared to grade 3 counterparts (Table 2; Fig. 2). The gene discussed is IDH2; the disease is central nervous system cancer.